药物输送
药品
巨噬细胞
药理学
医学
靶向给药
纳米载体
药物开发
体内
化学
毒品携带者
纳米技术
作者
Wen-Jie Xu,Jia-Xin Cai,Yong-Jiang Li,Jun-Yong Wu,Da-Xiong Xiang
标识
DOI:10.1007/s13346-021-01110-5
摘要
Nanoparticle drug delivery systems (NDDSs) are promising platforms for efficient delivery of drugs. In the past decades, many nanomedicines have received clinical approval and completed translation. With the rapid advance of nanobiotechnology, natural vectors are emerging as novel strategies to carry and delivery nanoparticles and drugs for biomedical applications. Among diverse types of cells, macrophage is of great interest for their essential roles in inflammatory and immune responses. Macrophage-derived vesicles (MVs), including exosomes, microvesicles, and those from reconstructed membranes, may inherit the chemotactic migration ability and high biocompatibility. The unique properties of MVs make them competing candidates as novel drug delivery systems for precision nanomedicine. In this review, the advantages and disadvantages of existing NDDSs and MV-based drug delivery systems (MVDDSs) were compared. Then, we summarized the potential applications of MVDDSs and discuss future perspectives. The development of MVDDS may provide avenues for the treatment of diseases involving an inflammatory process.Graphical abstract
科研通智能强力驱动
Strongly Powered by AbleSci AI